To provide a technique for improving the stability of a halogenated isoquinoline derivative with respect to light in an aqueous composition. A pharmaceutical preparation that is obtained by having an aqueous composition, which contains a compound represented by general formula (1), a salt thereof or a solvate of the compound or salt, contained in a package that blocks light having a wavelength of 300-335 nm. (In the formula, X represents a halogen atom.)
